Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-operative Imaging of Folate Receptor Alpha Positive Ovarian and Lung Cancer Using EC17
2013-004089-33Phase 2Completed
- Sponsor
- Centre for Human Drug Research
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of EC-17 in primary ovarian carcinoma and non-small cell lung cancer (NSCLC), sponsored by Centre for Human Drug Research. Primary endpoint: Concordance rate between pathology and imaging. Started Oct 2013; status: completed.
02
Drugs
EC-17
03
Conditions
primary ovarian carcinomanon-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2013-004089-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004089-33.